BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nie WY, Ye Y, Tong HX, Hu JQ. Herbal medicine as a potential treatment for non-alcoholic fatty liver disease. World J Gastroenterol 2025; 31(9): 100273 [PMID: 40061600 DOI: 10.3748/wjg.v31.i9.100273]
URL: https://www.wjgnet.com/1948-5182/full/v31/i9/100273.htm
Number Citing Articles
1
Yan-Chun Guo, Ye Hong, Li Huang, Xiao-Wei Xu, Jing-Qi Sun, Kang-Kang Ji, Chao-Nian Li. Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populationsWorld Journal of Gastroenterology 2025; 31(38): 112166 doi: 10.3748/wjg.v31.i38.112166
2
Yuyun Jia, Yanping Cao, Qin Yin, Xueqian Li, Xiu Wen. Identification of immune and major depressive disorder-related diagnostic markers for early nonalcoholic fatty liver disease by WGCNA and machine learningFrontiers in Bioinformatics 2025; 5 doi: 10.3389/fbinf.2025.1594971
3
Hui Zheng, Hang Li, Hang Du, Lisong Sheng, Nana Huang, Xiaonan Li, Rong Sun. Unravelling the mechanisms of erchen decoction in the treatment of nonalcoholic fatty liver disease (NAFLD): an integrative study combining network pharmacology, molecular docking, molecular dynamics simulation, multi-omics analysis, and experimental validationJournal of Ethnopharmacology 2025; 353: 120216 doi: 10.1016/j.jep.2025.120216
4
Mengxuan Hao, Zihui Wang, Liren Wang, Aidiya Yimamu, Xiaoling Su, Minmin Zhang, Xincan Li, Quanlong Zhang, Zeyu Sun. Flavonoids as modulators of gut-liver axis: emerging therapeutic strategies for MAFLDFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1657751